Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2759 | 1 | CTACK | 15.0 | 82 | |||||||
| RA1931 | 1 | CTACK | 17.0 | 80 | |||||||
| N2586 | 1 | CTACK | 15.0 | 68 | |||||||
| RA1869 | JNK-IN-8 | 3.0 | uM | 1 | CTACK | 17.0 | 55 | ||||
| RA1869 | PH-797804 | 0.6 | uM | 1 | CTACK | 19.0 | 61 | ||||
| N2759 | JNK-IN-8 | 3.0 | uM | 1 | CTACK | 16.0 | 72 | ||||
| N2759 | PH-797804 | 0.6 | uM | 1 | CTACK | 15.0 | 54 | ||||
| RA1931 | JNK-IN-8 | 3.0 | uM | 1 | CTACK | 15.5 | 48 | ||||
| RA1931 | PH-797804 | 0.6 | uM | 1 | CTACK | 16.0 | 65 | ||||
| N2586 | JNK-IN-8 | 3.0 | uM | 1 | CTACK | 22.0 | 42 | ||||
| N2586 | PH-797804 | 0.6 | uM | 1 | CTACK | 16.0 | 50 | ||||
| RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 18.0 | 51 | ||||
| RA1869 | IKK16 | 2.0 | uM | 1 | CTACK | 19.0 | 51 | ||||
| N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 15.0 | 66 | ||||
| N2759 | IKK16 | 2.0 | uM | 1 | CTACK | 20.0 | 65 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 18.0 | 75 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | CTACK | 16.5 | 68 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 16.0 | 74 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | CTACK | 17.0 | 58 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | CTACK | 18.0 | 57 | ||||
| RA1869 | 1 | CTACK | 18.0 | 79 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | CTACK | 17.0 | 71 | ||||
| N2759 | 1 | CTACK | 16.0 | 63 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | CTACK | 16.0 | 50 | ||||
| RA1931 | 1 | CTACK | 18.0 | 59 |